Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acsimethine Sustained-Release Capsules for Low Back Pain (Real-World, Single-Arm Study)
ChiCTR2600130633Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of acemetacin in lumbodynia (LBP), Herniated Lumbar Disk, lumbar spondylolisthesis and 2 more, sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Improvement rate in overall pain score (VAS) relative to baseline at week 4. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
acemetacin
03
Conditions
lumbodynia (LBP)Herniated Lumbar Disklumbar spondylolisthesisFacetogenic Lower Back PainLumbar soft tissue injury (LSTI)
Beyond the preview
Go deeper on ChiCTR2600130633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600130633.